Instil Bio Sets May 28th Annual Meeting
Ticker: TIL · Form: DEF 14A · Filed: Apr 14, 2025 · CIK: 1789769
| Field | Detail |
|---|---|
| Company | Instil Bio, INC. (TIL) |
| Form Type | DEF 14A |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting
TL;DR
Instil Bio's proxy statement is out for their May 28th annual meeting. Vote your shares!
AI Summary
Instil Bio, Inc. filed its definitive proxy statement for the annual meeting of stockholders to be held on May 28, 2025. The company, located at 3963 Maple Avenue, Suite 350, Dallas, TX 75219, is seeking shareholder approval for matters to be discussed at the meeting. The filing indicates no fee was required for this submission.
Why It Matters
This filing provides shareholders with crucial information regarding the upcoming annual meeting, including proposals to be voted on, which can impact corporate governance and future company direction.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting, not indicating any immediate financial distress or significant operational changes.
Key Players & Entities
- Instil Bio, Inc. (company) — Registrant
- May 28, 2025 (date) — Annual Meeting Date
- 3963 Maple Avenue, Suite 350, Dallas, TX 75219 (address) — Company Business Address
FAQ
When is Instil Bio, Inc.'s annual meeting of stockholders scheduled to take place?
The annual meeting of stockholders for Instil Bio, Inc. is scheduled to be held on May 28, 2025.
What is the filing type for this document?
This document is a Definitive Proxy Statement (DEF 14A).
Where is Instil Bio, Inc. located?
Instil Bio, Inc.'s business and mail address is 3963 Maple Avenue, Suite 350, Dallas, Texas 75219.
Was a filing fee required for this DEF 14A filing?
No, the filing indicates that no fee was required for this filing.
Under which section of the Securities Exchange Act of 1934 is this proxy statement filed?
This proxy statement is filed pursuant to Section 14(a) of the Securities Exchange Act of 1934.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 14, 2025 regarding Instil Bio, Inc. (TIL).